1. Stocks
  2. Mirum Pharmaceuticals Inc
  3. Swot
swot-logo

Mirum Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mirum Pharmaceuticals Inc has 18 Strengths, 7 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent Highest Return Stocks over Five Years - Nifty500

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

Momentum Trap (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Companies with Increasing Debt

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks